-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BkNAim6ewjAb5OdG4/T9jfSvRqBeDHUbrMLAeszunC2ZS8yp6YfwbQaMG3yGoP6+ nBJ0dPZplrwsGQHtSVUrbA== 0001179110-08-013530.txt : 20080710 0001179110-08-013530.hdr.sgml : 20080710 20080710141252 ACCESSION NUMBER: 0001179110-08-013530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080708 FILED AS OF DATE: 20080710 DATE AS OF CHANGE: 20080710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 08946832 BUSINESS ADDRESS: BUSINESS PHONE: 650-574-3000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 4 1 edgar.xml FORM 4 - X0303 4 2008-07-08 0 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 0 0 Chairman and CEO Common Stock 2008-07-08 4 M 0 70000 3.6485 A 1620229 D Common Stock 2008-07-08 4 S 0 884 53.08 D 1619345 D Common Stock 2008-07-08 4 S 0 4700 53.07 D 1614645 D Common Stock 2008-07-08 4 S 0 4416 53.01 D 1610229 D Common Stock 2008-07-08 4 S 0 5600 53.06 D 1604629 D Common Stock 2008-07-08 4 S 0 9400 53.00 D 1595229 D Common Stock 2008-07-08 4 S 0 900 52.97 D 1594329 D Common Stock 2008-07-08 4 S 0 200 52.92 D 1594129 D Common Stock 2008-07-08 4 S 0 9800 52.90 D 1584329 D Common Stock 2008-07-08 4 S 0 10000 52.75 D 1574329 D Common Stock 2008-07-08 4 S 0 6600 52.71 D 1567729 D Common Stock 2008-07-08 4 S 0 10000 52.69 D 1557729 D Common Stock 2008-07-08 4 S 0 7500 52.70 D 1550229 D Non-Qualified Stock Option 3.6485 2008-07-08 4 M 0 70000 0 D 2009-07-21 Common Stock 70000 873376 D Amount of securities beneficially owned following the reported transaction includes 792 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2008. Options vested over a five year period with 20% vesting July 22, 2000, the first anniversary of the grant. The options continued to vest in quarterly installments over the next four years, and was fully vested on July 22, 2004. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on August 29, 2006. /s/ Matthew Au by Power of Attorney for John C. Martin 2008-07-08 -----END PRIVACY-ENHANCED MESSAGE-----